4//SEC Filing
Lim Bryant David 4
Accession 0001415889-22-007545
CIK 0000861838other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:33 PM ET
Size
5.6 KB
Accession
0001415889-22-007545
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2022-07-06+66,500→ 66,500 totalExercise: $0.43Exp: 2032-07-06→ Common Stock (66,500 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on July 6, 2026, with 25% vesting on July 6, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001752888
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:33 PM ET
- Size
- 5.6 KB